Beckwith-wiedemann syndrome: Growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance

Hormone Research in Paediatrics

Volumn 80, Issue 6, 2014, Pages 457-465

  Brioude, F ^a,b,c,d   Lacoste, A ^a   Netchine, I ^a,b,c,d   Vazquez, M P ^a,e   Auber, F ^b,f   Audry, G ^b,f   Gauthier Villars, M ^g   Brugieres, L ^h   Gicquel, C ^h   Le Bouc, Y ^a,b,c,d   Rossignol, S ^a,b,c,d  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Centre des Maladies Endocriniennes Rares de la Croissance   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Centre de Référence des Malformations Rares de la Face et de la Cavité Buccale   (France)

^f INSTITUT CURIE   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h Epigenetics in Human Health and Disease Laboratory   (Australia)

Author keywords

Beckwith Wiedemann syndrome; Epigenetics; Growth; Phenotype; Tumors

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C;

11P15 PATERNAL UNIPARENTAL ISODISOMY; ADRENAL CORTEX CARCINOMA; ARTICLE; BECKWITH WIEDEMANN SYNDROME; BIRTH WEIGHT; BODY HEIGHT; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CHILD; CHILD GROWTH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENOME IMPRINTING; HEPATOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; MOLECULAR DIAGNOSIS; NEPHROBLASTOMA; NEUROBLASTOMA; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHABDOMYOSARCOMA; SCHOOL CHILD; UMBILICAL HERNIA; UNIPARENTAL DISOMY; ADULT; BODY GROWTH; DISEASE SURVEILLANCE; FOLLOW UP; INFANCY; LENGTH; MOLECULAR DYNAMICS; PHENOTYPE; PREVALENCE;

ADULT; BECKWITH-WIEDEMANN SYNDROME; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MONITORING, PHYSIOLOGIC; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84893108449     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000355544     Document Type: Article

References (48)

1. Engel JR, Smallwood A, Harper A, Higgins MJ, Oshimura M, Reik W, Schofield PN, Maher ER: Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet 2000; 37: 921-926.
2. Demars J, Le Bouc Y, El-Osta A, Gicquel C: Epigenetic and genetic mechanisms of abnormal 11p15 genomic imprinting in Silver-Russell and Beckwith-Wiedemann syndromes. Curr Med Chem 2011; 18: 1740-1750.
3. Mussa A, Peruzzi L, Chiesa N, De Crescenzo A, Russo S, Melis D, Tarani L, Baldassarre G, Larizza L, Riccio A, Silengo M, Ferrero GB: Nephrological findings and genotype-phenotype correlation in Beckwith-Wiedemann syndrome. Pediatr Nephrol 2012; 27: 397-406.
4. Cooper WN, Luharia A, Evans GA, Raza H, Haire AC, Grundy R, Bowdin SC, Riccio A, Sebastio G, Bliek J, Schofield PN, Reik W, Macdonald F, Maher ER: Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 2005; 13: 1025-1032.
5. Gaston V, Le Bouc Y, Soupre V, Burglen L, Donadieu J, Oro H, Audry G, Vazquez MP, Gicquel C: Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. Eur J Hum Genet 2001; 9: 409-418.
6. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, DePinho RA, Elledge SJ: Altered cell differentiation and proliferation in mice lacking p57kip2 indicates a role in Beckwith-Wiedemann syndrome. Nature 1997; 387: 151-158.
7. Schneid H, Seurin D, Vazquez MP, Gourmelen M, Cabrol S, Le Bouc Y: Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome. J Med Genet 1993; 30: 353-362.
8. Best LG, Hoekstra RE: Wiedemann-Beckwith syndrome: Autosomal-dominant inheritance in a family. Am J Med Genet 1981; 9: 291-299.
9. Smith DW: Recognizable patterns of human malformation. Genetic, embryologic and clinical aspects. Third edition. Major Probl Clin Pediatr 1982; 7: 1-653.
10. Niikawa N, Ishikiriyama S, Takahashi S, Inagawa A, Tonoki H, Ohta Y, Hase N, Kamei T, Kajii T: The Wiedemann-Beckwith syndrome: Pedigree studies on five families with evidence for autosomal dominant inheritance with variable expressivity. Am J Med Genet 1986; 24: 41-55.
11. Weksberg R, Shuman C, Beckwith JB: Beckwith-Wiedemann syndrome. Eur J Hum Genet 2010; 18: 8-14.
12. Pettenati MJ, Haines JL, Higgins RR, Wappner RS, Palmer CG, Weaver DD: Wiedemann-Beckwith syndrome: Presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet 1986; 74: 143-154.
13. Sippell WG, Partsch CJ, Wiedemann HR: Growth, bone maturation and pubertal development in children with the EMG-syndrome. Clin Genet 1989; 35: 20-28.
14. Viljoen D, Ramesar R: Evidence for paternal imprinting in familial Beckwith-Wiedemann syndrome. J Med Genet 1992; 29: 221-225.
15. Elliott M, Bayly R, Cole T, Temple IK, Maher ER: Clinical features and natural history of Beckwith-Wiedemann syndrome: Presentation of 74 new cases. Clin Genet 1994; 46: 168-174.
16. Greer KJ, Kirkpatrick SJ, Weksberg R, Pauli RM: Beckwith-Wiedemann syndrome in adults: Observations from one family and recommendations for care. Am J Med Genet A 2008; 146A:1707-1712.
17. Poole RL, Leith DJ, Docherty LE, Shmela ME, Gicquel C, Splitt M, Temple IK, Mackay DJ: Beckwith-Wiedemann syndrome caused by maternally inherited mutation of an OCTbinding motif in the IGF2/H19-imprinting control region, ICR1. Eur J Hum Genet 2012; 20: 240-243.
18. Berland S, Appelback M, Bruland O, Beygo J, Buiting K, Mackay DJ, Karen Temple I, Houge G: Evidence for anticipation in Beckwith-Wiedemann syndrome. Eur J Hum Genet, E-pub ahead of print.
19. Schneid H, Vazquez MP, Vacher C, Gourmelen M, Cabrol S, Le Bouc Y: The Beckwith-Wiedemann syndrome phenotype and the risk of cancer. Med Pediatr Oncol 1997; 28: 411-415.
20. DeBaun MR, Tucker MA: Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann syndrome registry. J Pediatr 1998; 132: 398-400.
21. Bliek J, Maas SM, Ruijter JM, Hennekam RC, Alders M, Westerveld A, Mannens MM: Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: Occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. Hum Mol Genet 2001; 10: 467-476.
22. Weksberg R, Nishikawa J, Caluseriu O, Fei YL, Shuman C, Wei C, Steele L, Cameron J, Smith A, Ambus I, Li M, Ray PN, Sadowski P, Squire J: Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1 . Hum Mol Genet 2001; 10: 2989-3000.
23. DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP: Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 2002; 70: 604-611.
24. Bliek J, Gicquel C, Maas S, Gaston V, Le Bouc Y, Mannens M: Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 2004; 145: 796-799.
25. Choyke PL, Siegel MJ, Craft AW, Green DM, DeBaun MR: Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 1999; 32: 196-200.
26. McNeil DE, Brown M, Ching A, DeBaun MR: Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: A cost-effective model. Med Pediatr Oncol 2001; 37: 349-356.
27. Green DM, Breslow NE, Beckwith JB, Norkool P: Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: A report from the National Wilms Tumor Study. Med Pediatr Oncol 1993; 21: 188-192.
28. Craft AW, Parker L, Stiller C, Cole M: Screening for Wilms tumour in patients with aniridia, Beckwith syndrome, or hemihypertrophy. Med Pediatr Oncol 1995; 24: 231-234.
29. Scott RH, Walker L, Olsen OE, Levitt G, Kenney I, Maher E, Owens CM, Pritchard-Jones K, Craft A, Rahman N: Surveillance for Wilms tumour in at-risk children: Pragmatic recommendations for best practice. Arch Dis Child 2006; 91: 995-999.
30. Clericuzio CL, Chen E, McNeil DE, O'Connor T, Zackai EH, Medne L, Tomlinson G, De-Baun M: Serum α-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 2003; 143: 270-272.
31. Azzi S, Steunou V, Rousseau A, Rossignol S, Thibaud N, Danton F, Le Jule M, Gicquel C, Le Bouc Y, Netchine I: Allele-specific methylated multiplex real-Time quantitative PCR (ASMM RT-q-PCR), a powerful method for diagnosing loss of imprinting of the 11p15 region in Russell-Silver and Beckwith-Wiedemann syndromes. Hum Mutat 2011; 32: 249-258.
32. Gaston V, Le Bouc Y, Soupre V, Vazquez MP, Gicquel C: Assessment of p57 kip2 gene mutation in Beckwith-Wiedemann syndrome. Horm Res 2000; 54: 1-5.
33. Usher R, McLean F: Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 1969; 74: 901-910.
34. Sempe M, Pedron G, Roy-Pernot MP: Passage from childhood to adolescence. II. Sequential study of the development of puberty in 49 girls (in French). Probl Actuels Endocrinol Nutr 1973; 16: 9-71.
35. Lacour B, Guyot-Goubin A, Guissou S, Bellec S, Desandes E, Clavel J: Incidence of childhood cancer in France: National Children Cancer Registries, 2000-2004. Eur J Cancer Prev 2009; 19: 173-181.
36. Abadie C, Bernard F, Netchine I, Sanlaville D, Roque A, Rossignol S, Coupier I: Acute lymphocytic leukaemia in a child with Beckwith-Wiedemann syndrome harbouring a CDKN1C mutation. Eur J Med Genet 2010; 53: 400-403.
37. Eggermann T, Algar E, Lapunzina P, Mackay D, Maher ER, Mannens M, Netchine I, Prawitt D, Riccio A, Temple IK, Weksberg R: Clinical utility gene card for Beckwith-Wiedemann syndrome. Eur J Hum Genet, E-pub ahead of print.
38. Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF, et al: Insulin-like growth factor-II gene expression in Wilms tumour and embryonic tissues. Nature 1985; 317: 260-262.
39. Ravenel JD, Broman KW, Perlman EJ, Niemitz EL, Jayawardena TM, Bell DW, Haber DA, Uejima H, Feinberg AP: Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms' tumor. J Natl Cancer Inst 2001; 93: 1698-1703.
40. Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M, Louvel A, Luton JP, Le Bouc Y: Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: Study on a series of 82 tumors. J Clin Endocrinol Metab 1997; 82: 2559-2565.
41. Grundy P, Telzerow P, Paterson MC, Haber D, Berman B, Li F, Garber J: Chromosome 11 uniparental isodisomy predisposing to embryonal neoplasms. Lancet 1991; 338: 1079-1080.
42. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP: Relaxation of imprinted genes in human cancer. Nature 1993; 362: 747-749.
43. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE: Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms tumour. Nature 1993; 362: 749-751.
44. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE: Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci USA 1995; 92: 2159-2163.
45. Fukuzawa R, Anaka MR, Heathcott RW, Mc-Noe LA, Morison IM, Perlman EJ, Reeve AE: Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes. J Pathol 2008; 215: 377-387.
46. Cardoso LC, Tenorio Castano JA, Pereira HS, Lima MA, Dos Santos AC, de Faria PS, Ferman S, Seuanez HN, Nevado JB, de Almeida JC, Lapunzina P, Vargas FR: Constitutional and somatic methylation status of DMRH19 and KvDMR in Wilms tumor patients. Genet Mol Biol 2012; 35: 714-724.
47. Everman DB, Shuman C, Dzolganovski B, O'Riordan MA, Weksberg R, Robin NH: Serum α-fetoprotein levels in Beckwith-Wiedemann syndrome. J Pediatr 2000; 137: 123-127.
48. Rump P, Zeegers MP, van Essen AJ: Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-Analysis. Am J Med Genet A 2005; 136: 95-104.